Sponsors / Collaborators
University of San Diego
Phase 1
N/A
Sponsors / Collaborators
Adamas Pharmaceuticals, Epilepsy Foundation (EF)
Sponsors / Collaborators
Aquestive Therapeutics
New Formulations and Indications
Convection Enhanced Delivery of Anticonvulsant Toxins for the Treatment of Intractable Partial Epilepsy
Preclinical
N/A
Sponsors / Collaborators
University of California Davis; Medgenesis Therapeutix, Epilepsy Foundation (EF)
Sponsors / Collaborators
King Pharmaceuticals; Pfizer
Sponsors / Collaborators
Xeris Pharmaceuticals, Inc., Epilepsy Foundation (EF)
Sponsors / Collaborators
Cerebral Therapeutics, EF
Preclinical
N/A
Sponsors / Collaborators
New York University, School of Medicine, EF
Sponsors / Collaborators
Greenwich Biosciences
Sponsors / Collaborators
BioLink Life Sciences, Inc.
Disclaimer
The Epilepsy Foundation makes no claims of accuracy of the following data. Although every effort is made to continuously update this list, some errors are inevitable. Companies or academicians or others who are directly involved with any of the therapies listed here are strongly encouraged to keep us updated by contacting contactus@efa.org of any needed changes.